ESALY:
Analysis & Opinions
-
November 14, 2012
Switzerland-based pharmaceutical company, Novartis AG (NVS) recently announced positive data on its pipeline ...
-
November 09, 2012
Arena Pharmaceuticals Inc.'s (ARNA) loss (excluding special items) of 7 cents per share in the third quarter of 2012 ...
-
November 08, 2012
Vivus Inc. (VVUS) reported a loss of 40 cents per share in the third quarter of 2012, wider than the Zacks Consensus ...
-
October 22, 2012
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently did not ...
-
September 25, 2012
Vivus Inc. (VVUS) recently announced that it expects the European Medicines Agency's (EMA) Committee for Medicinal ...
-
September 20, 2012
Vivus Inc. (VVUS) recently announced the launch of its obesity drug, Qsymia, in the US following the US Food and ...
